Related Experiment Video
Updated: Aug 23, 2026

Visualization and Quantitative Analysis of Genotoxin-Induced PARP1/PARP2 Activation in Cells Using a Fluorescent Fusion Protein-Based Reporter
Published on: April 17, 2026
Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone
K Hirose1, Y Kawasaki, K Kotani
1Clinical Research Center of Animal Health, Meiji Seika Kaisha Ltd, Yokohama, Kanagawa 222-8567.
Abstract:
Quinolone-resistant (QR) mutants of Mycoplasma bovirhinis strain PG43 (type strain) were generated by stepwise selection in increasing concentrations of enrofloxacin (ENR). An alteration was found in the quinolone resistance-determining region (QRDR) of the parC gene coding for the ParC subunit of topoisomerase IV from these mutants, but not in the gyrA, gyrB, and parE gene coding for the GyrA and GyrB subunits of DNA gyrase and the ParE subunit of topoisomerase IV. Similarly, such an alteration in QRDR of parC was found in the field isolates of M. bovirhinis, which possessed various levels of QR. The substitution of leucine (Leu) by serine (Ser) at position 80 of QRDR of ParC was observed in both QR-mutants and QR-isolates. This is the first report of QR based on a point mutation of the parC gene in M. bovirhinis.
Insights
Quinolone resistance in Mycoplasma bovirhinis is linked to a specific mutation in the parC gene. This finding, observed in both lab-generated mutants and field isolates, identifies a key genetic marker for enrofloxacin resistance.
Area of Science:
- Veterinary Microbiology
- Molecular Biology
- Antimicrobial Resistance
Background:
- Mycoplasma bovirhinis is a significant pathogen in cattle.
- Quinolone antibiotics, like enrofloxacin, are used to treat bacterial infections.
- Emergence of quinolone resistance (QR) is a growing concern in veterinary medicine.
Purpose of the Study:
- To investigate the genetic basis of quinolone resistance in Mycoplasma bovirhinis.
- To identify specific gene mutations associated with enrofloxacin resistance in this species.
Main Methods:
- Stepwise selection of Mycoplasma bovirhinis strain PG43 with increasing enrofloxacin concentrations to generate resistant mutants.
- Analysis of the quinolone resistance-determining regions (QRDR) of key genes, including parC, gyrA, gyrB, and parE.
- Sequencing of the parC gene in both laboratory-generated mutants and field isolates exhibiting quinolone resistance.
Main Results:
- Quinolone-resistant mutants of Mycoplasma bovirhinis exhibited an alteration in the QRDR of the parC gene.
- This specific parC gene alteration, a leucine to serine substitution at position 80, was also identified in field isolates of M. bovirhinis with varying levels of quinolone resistance.
- No alterations were found in the gyrA, gyrB, or parE genes in the resistant strains.
Conclusions:
- The study identifies a point mutation in the parC gene as the primary mechanism conferring quinolone resistance in Mycoplasma bovirhinis.
- This parC gene mutation is a reliable marker for quinolone resistance in both experimental and naturally occurring infections.
- This is the first report detailing quinolone resistance in M. bovirhinis mediated by a parC gene mutation.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial DNA Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
